I talked with Reach Radio about alliances at the intersection of health tech, innovative services, and behavioral health over my past 20 yrs. Check it out:
"Empowering Patients With Digital Health Experiences"
https://t.co/VkcKtb8kpS
#healthtech
Excited to share an article I co-wrote for Pharma Exec about The Architecture of Global, Scalable, Next-Generation Patient Support Programs. IvyTree Advisors helps digital health & pharma companies help patients! https://t.co/bLmgnF91RN
#digitalhealth#patients#IvyTreeAdvisors
A shortage of hospital staff will outlast omicron.
Exhaustion, low pay and poor conditions have pushed nurses and doctors to change jobs.
In-home care, lab testing and the private sector beckon. Violence from their own patients has disillusioned them https://t.co/Yb3pDTHtlp
Big theme at #HLTH this year said on multiple panels: the story of the patient is told through data, so the patient journey and data are now inseparable.
Coinbase is now valued above $100 billion, per a secondary sale organized by the company.
$141m profit on $691m revenue for first nine months of 2020.
(wrong link before) https://t.co/IZGaC5glUm
@realDonaldTrump How can we get more people to share their covid symptoms online so we know where the hot zones are ramping? Could this tell us where to quarantine, send test kits, and provide missing resources? #COVID19
Many of you know that I am inspired to fix big problems in health and pharma using technology. Turns out the fax machine, invented in 1843, is still backbone of the US Health Information Exchange (HIE). More on my recent medical record adventue at https://t.co/bIZP0zomR0
Congrats to the @everly_well team and CEO @JuliaTCheek for closing their $50M Series B and showing such great traction. Proud to be an early investor with @NextGenVP https://t.co/AALXYy5Kq6
Fantastic to see the FDA approve the only oral, short-course therapy for MS for relapsing and secondary progressive multiple sclerosis #mavenclad. Glad to contribute alongside the awesome team @merckgroup. This is a huge win for MS patients.
JUST NOW:
The #FDA has approved #cladribine (#Mavenclad, @EMDSerono) an oral therapy for the treatment of relapsing #multiplesclerosis, as well as active secondary progressive MS.
https://t.co/oi8GGY0rew
Excited to announce the launch of Ivy Tree Advisors, a new consultancy providing strategy, commercialization, and product launch services for health, tech, and life science companies. Learn more at https://t.co/Mrs0Iy53BA